DE69231423T2 - Verfahren und Zusammensetzung zur Behandlung von Infektionen unter Verwendung von optisch reinem (R) - Lomefloxacin - Google Patents

Verfahren und Zusammensetzung zur Behandlung von Infektionen unter Verwendung von optisch reinem (R) - Lomefloxacin

Info

Publication number
DE69231423T2
DE69231423T2 DE69231423T DE69231423T DE69231423T2 DE 69231423 T2 DE69231423 T2 DE 69231423T2 DE 69231423 T DE69231423 T DE 69231423T DE 69231423 T DE69231423 T DE 69231423T DE 69231423 T2 DE69231423 T2 DE 69231423T2
Authority
DE
Germany
Prior art keywords
lomefloxacin
treatment
optically pure
infections
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231423T
Other languages
English (en)
Other versions
DE69231423D1 (de
Inventor
W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DE69231423D1 publication Critical patent/DE69231423D1/de
Publication of DE69231423T2 publication Critical patent/DE69231423T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69231423T 1991-11-27 1992-11-25 Verfahren und Zusammensetzung zur Behandlung von Infektionen unter Verwendung von optisch reinem (R) - Lomefloxacin Expired - Fee Related DE69231423T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80066891A 1991-11-27 1991-11-27
PCT/US1992/010144 WO1993010786A1 (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (r)-lomefloxacin

Publications (2)

Publication Number Publication Date
DE69231423D1 DE69231423D1 (de) 2000-10-12
DE69231423T2 true DE69231423T2 (de) 2001-01-04

Family

ID=25179035

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231423T Expired - Fee Related DE69231423T2 (de) 1991-11-27 1992-11-25 Verfahren und Zusammensetzung zur Behandlung von Infektionen unter Verwendung von optisch reinem (R) - Lomefloxacin

Country Status (11)

Country Link
EP (1) EP0661974B1 (de)
JP (1) JPH07501546A (de)
AT (1) ATE196085T1 (de)
AU (2) AU3223693A (de)
CA (1) CA2124444A1 (de)
DE (1) DE69231423T2 (de)
DK (1) DK0661974T3 (de)
ES (1) ES2149196T3 (de)
GR (1) GR3034919T3 (de)
PT (1) PT661974E (de)
WO (1) WO1993010786A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190777A (ja) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd 光学活性な6,8−ジフルオロ−1,4−ジヒドロ−4−オキソ−7−置換ピペラジニルキノリン−3−カルボン酸誘導体
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物i型結晶の製造法

Also Published As

Publication number Publication date
AU3223693A (en) 1993-06-28
EP0661974A4 (de) 1994-08-29
JPH07501546A (ja) 1995-02-16
ES2149196T3 (es) 2000-11-01
PT661974E (pt) 2001-02-28
AU1515297A (en) 1997-05-22
ATE196085T1 (de) 2000-09-15
EP0661974B1 (de) 2000-09-06
DK0661974T3 (da) 2000-10-16
CA2124444A1 (en) 1993-06-10
DE69231423D1 (de) 2000-10-12
WO1993010786A1 (en) 1993-06-10
GR3034919T3 (en) 2001-02-28
EP0661974A1 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
DE69226844T2 (de) Verfahren zur Herstellung von L-Isoleucin
DE69228640D1 (de) Verfahren zur Herstellung von L-Threonin
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE69129115D1 (de) Neues verfahren zur behandlung von depression
DE69117768D1 (de) Neues verfahren zur darstellung von formoterol und vewandten verbindungen
DE69318909T2 (de) Verfahren zur Herstellung von menschlichem Wachstumshormon
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69027585D1 (de) Verfahren zur Herstellung von optisch reinen Diastereoisomeren von Tetrahydrofolatverbindungen
DE69231423D1 (de) Verfahren und Zusammensetzung zur Behandlung von Infektionen unter Verwendung von optisch reinem (R) - Lomefloxacin
DE69228648D1 (de) Verfahren zur Herstellung von komplementären, bipolaren Transistoren
DE69210069T2 (de) Verfahren zur Herstellung von 1,3-Dioxolen
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE69118001D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten
DE59209261D1 (de) Verfahren zur Herstellung von substituierten 3-Alkoxy-acrylestern
DE69207955T2 (de) Verfahren zur Herstellung von Estern von racemierbaren Säuren
DE69600933D1 (de) Verfahren zur Herstellung von photographischen Elementen enthaltend beladene Latexzusammensetzungen
DE69119488T2 (de) Disulfat von WS-7622A, Verfahren zur Herstellung und Benutzung
DE59200254D1 (de) Verfahren zur Herstellung von N-(Hydroxyalkyl)-carbamidsäure- alkylestern.
DE69116499T2 (de) Verfahren zur Herstellung von Alpha-Hydroxyketonen
DE59600315D1 (de) Verfahren zur Herstellung von acetylenisch ungesättigten Verbindungen
DE59205953D1 (de) Verfahren zur Herstellung von Cycloalkanolen
DE69218729T2 (de) Verfahren zur Herstellung von (+)-Estronderivaten
DE69127219D1 (de) Verfahren zur Herstellung von optisch aktiven Alkyl-3-aryl-3-hydroxypropionaten
DE59107283D1 (de) Verfahren zur Herstellung von racemischen Pilosinin-Derivaten
DE59206420D1 (de) Verfahren zur Herstellung von Cycloalkanolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee